Investigation of isepamicin in-vitro efficiency in Gram negative bacteria-Reference-Cited by-同舟云学术

Investigation of isepamicin in-vitro efficiency in Gram negative bacteria

Published:2021-01 Issue:1 Volume:39 Page:59-62
ISSN:0255-0857
Container-title:Indian Journal of Medical Microbiology
language:en
Short-container-title:Indian Journal of Medical Microbiology

Author:

Yeliz Tanriverdi Cayci,Ali Hosseini Baghanam,Sarah Al-Furais,Sreylis Nay,Kubra Hacieminoglu Ulker,Asuman Birinci

Publisher

Elsevier BV

Subject

Microbiology (medical)

Reference27 articles.

1. The changing nature of aminoglycoside resistance mechanisms and the role of isepamicin a new broad-spectrum aminoglycoside. The Aminoglycoside Resistance Study Groups;Miller;J XChemother,1995

2. The most frequent aminoglycoside resistance mechanisms--changes with time and geographic area: a reflection of aminoglycoside usage patterns? Aminoglycoside Resistance Study Groups;Miller;Clin Infect Dis,1997

3. In vitro activity of aminoglycosides against clinical isolates of Acinetobacter baumannii complex and other nonfermentative Gram-negative bacilli causing healthcare-associated bloodstream infections in Taiwan;Liu;J Microbiol Immunol Infect,2016

4. In vivo analysis of structure-activity relationships among four aminoglycosides: gentamicin, netilmicin, 1-N HAPA gentamicin B and amikacin;Goering;Curr Ther Res Clin Exp,1979

5. The syntheses and biological properties of 1-N-(S-4-amino-2-hydroxybutyryl)-gentamicin B and 1-N-(S-3-amino-2-hydroxypropionyl)-gentamicin B;Nagabhushan;The J of Antibio,1978

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can isepamicin be a potential option for extended spectrum beta-lactamases and carbapenemases expressing Escherichia coli?;Clinical Epidemiology and Global Health;2024-01